Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    Loans
    HomeNewsPiramal life sciences

    Piramal Life Sciences

    Jump to

    • Check out: Buzzing small cap stocks on September 03

      Here's how small cap stocks opened on September 03

    • Piramal Life standalone Jun '13 sales at Rs 0.31 crore

      Piramal Life Sciences has reported a standalone sales turnover of Rs 0.31 crore and a net loss of Rs 1.56 crore for the quarter ended Jun '13

    • Piramal Life standalone Mar '13 sales at Rs 0.88 crore

      Piramal Life Sciences has reported a standalone sales turnover of Rs 0.88 crore and a net loss of Rs 0.97 crore for the quarter ended Mar '13

    • Piramal Life standalone Dec '12 sales at Rs 1.65 crore

      Piramal Life Sciences has reported a standalone sales turnover of Rs 1.65 crore and a net loss of Rs 1.33 crore for the quarter ended Dec '12

    • PHL Holdings sells 72.93 lakh shares of Piramal Life

      On December 28, 2012 PHL Holdings Private Limited sold 7,293,480 shares of Piramal Life Sciences at Rs 36 on the BSE. In the previous trading session, the share closed at Rs 39.70, up Rs 1.85, or 4.89%.

    • Block deal in Piramal Life Sciences; stock gains 4.8%

      There was a block deal of 28.09% equity shares of Piramal Life Sciences on BSE at Rs 36 per share, reports CNBC-TV18. At 10:04 hrs Piramal Life Sciences was quoting at Rs 39.70, up Rs 1.85, or 4.89%.

    • BSE to shift 81 scrips into Trade-to-Trade segment

      As a part of surveillance measures, the Bombay Stock Exchange is going to transfer 81 scrips for settlement on a trade-to-trade basis. Some of them are 3i Infotech, Marksans Pharma, Moser Baer, Parenteral Drugs and Piramal Life Sciences.

    • Deal with Eli Lilly, Merck on track: Piramal Healthcare

      Swati Piramal, director of Piramal Healthcare tells CNBC-TV18 that it is one of the few pharma companies which are pushing for drug discovery.

    • Piramal Healthcare may see 30% upside: PN Vijay

      Piramal Healthcare may see 30% upside, says PN Vijay, Portfolio Manager, pnvijay.com.

    • Piramal to boost financial business

      Diversified conglomerate Piramal Group plans to lend up to USD 193 million to real estate projects in the current fiscal year to March as it focuses on building its newly launched financial arm, its chairman said.

    • Piramal Glass sees cosmetics biz capacity up 40% in FY12

      Glass falconage maker Piramal Glass expects to raise capacity of its cosmetics and perfumes bottles by about 40% to 550 tonne a day by March, as it looks to capitalise on low-cost advantage to draw more business from Europe.

    • Piramal Life, Biotech Dept start Phase 2 of drug project

      A Central Government Department and Piramal Life Sciences Ltd (PLSL) have launched Phase II of their joint project to find new drugs from 14,000 bioactive cultures discovered in a nationwide search.

    • Piramal Life gains 14% post demerger news

      At 09:20 hrs Piramal Life Sciences was quoting at Rs 112.95, up Rs 14.05, or 14.21% on the NSE. Piramal Life said that the board has okayed demerger of new chemical entity research unit. The swap ratio will be 1 share of Piramal Health for each 4 held, reports CNBC-TV18.

    • Piramal board approves demerger of New Chemical Entity

      The board of Piramal Healthcare has approved the demerger of the New Chemical Entity from Piramal Life Sciences and merging it into itself. Shareholders will be issues one share of parent Piramal Healthcare for every four shares of Life Sciences.

    • Piramal Life Mar '11 sales at Rs 0.69 crore

      Piramal Life Sciences has reported a sales turnover of Rs 0.69 crore and a net loss of Rs 40.97 crore for the quarter ended Mar '11

    • Block Deal: 10 lakh Piramal Life shares changed hands on BSE; up 28% in 7 days

      Piramal Life Sciences touched an intraday high of Rs 112 and an intraday low of Rs 105.60. At 11:21 hrs the share was quoting at Rs 109.30, up Rs 1.65, or 1.53%.

    • SP Tulsian's multi-bagger ideas for the day

      In an interview with CNBC-TV18, SP Tulsian of sptulsian.com gave some multi-bagger recommendations for investors.

    • Piramal Life Sciences dips 8% on profit booking

      Piramal Life Sciences touched an intraday high of Rs 130.65 and an intraday low of Rs 110.90. At 14:37 hrs the share was quoting at Rs 112, down Rs 10.40, or 8.50%.

    • Pharma firms want tax cuts, R&D sops boost

      Drugmakers want tax exemption deadline for export oriented unit (EOUs) to be extended and want infrastructure or priority sector status in the budget on Feb 28.

    • Piramal Life Dec '10 sales at Rs 13.98 crore

      Piramal Life Sciences has reported a sales turnover of Rs 13.98 crore and a net loss of Rs 25.68 crore for the quarter ended Dec '10

    • Piramal Life Sciences Q3 net loss Rs 25.6 cr

      Piramal Life Sciences Q3FY11 revenue was at Rs 14 crore versus Rs 1.22 crore, YoY.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347